42 U.S.C. § 300b-12 — Laboratory quality and surveillance

(a) In general The Secretary , acting through the Director of the Centers for Disease Control and Prevention and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b–10 of this title , shall provide for— (1) quality assurance for laboratories involved in screening newborns and children for heritable disorders, including quality assurance for newborn-screening tests, timeliness for processing such tests, performance evaluation services , and technical assistance and technology transfer to newborn screening laboratories to ensure analytic validity and utility of screening tests; and (2) appropriate quality control and other performance test materials to evaluate the performance of new screening tools. (b) Surveillance activities The Secretary , acting through the Director of the Centers for Disease Control and Prevention , and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b–10 of this title , may provide, as appropriate, for the coordination of surveillance activities, including— (1) through standardized data collection and reporting, as well as the use of electronic health records; and (2) by promoting data sharing regarding newborn screening with State-based birth defects and developmental disabilities monitoring programs. (July 1, 1944, ch. 373, title XI, § 1113, as added Pub. L. 110–204, § 6 , Apr. 24, 2008 , 122 Stat. 710 ; amended Pub. L. 110–237, § 1(a)(5) , May 27, 2008 , 122 Stat. 1557 ; Pub. L. 113–240, § 6 , Dec. 18, 2014 , 128 Stat. 2854 .) Editorial Notes Amendments 2014— Pub. L. 113–240, § 6(1) , inserted “and surveillance” after “quality” in section catchline. Subsec. (a). Pub. L. 113–240, § 6(2)(A) , substituted “and taking into consideration the expertise of the Advisory Committee” for “and in consultation with the Advisory Committee” in introductory provisions. Subsec. (a)(1). Pub. L. 113–240, § 6(2)(B) , inserted “timeliness for processing such tests,” after “newborn-screening tests,”. Subsec. (b). Pub. L. 113–240, § 6(3) , added subsec. (b) and struck out former subsec. (b). Prior to amendment, text read as follows: “For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for fiscal year 2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.” 2008—Subsec. (b). Pub. L. 110–237 substituted “2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.” for “2008, $5,062,500 for fiscal year 2009, $5,125,000 for fiscal year 2010, $5,187,500 for fiscal year 2011, and $5,250,000 for fiscal year 2012.”

Related documents

• 16 U.S.C. § 742d — Investigations; preparation and dissemination of information; reports#569755
• 5 U.S.C. § 1303 — Investigations; reports#556487
• 30 U.S.C. § 1252 — Initial regulatory procedures#584385
• 15 U.S.C. § 1472 — Special packaging standards#566706
• 42 U.S.C. § 16161e — Laboratory management#589063